Scott Coon, PharmD, BCACP

Assistant Professor, Department of Pharmacotherapeutics & Clinical Research., Taneja College of Pharmacy

Contact Info

• 12901 Bruce B. Downs Blvd.
  MDC 30
  Tampa FL 33612
• Academic Email: scoon1@usf.edu
• Academic Phone: (813) 974-9713
• View My C.V. | View My Website

Education

Academic Philosophy

Interdisciplinary and Emerging Signature Programs

• Cardiovascular
• Other

Research Interests

• Opioid use disorder is a devastating chronic illness, yet the majority of patients receive no treatment. There are tremendous barriers for patients trying to access care, especially for those seeking medication-based treatment. Dr. Coon is interested in identifying and correcting treatment barriers and disparities caused by state/federal regulations, healthcare systems, stigma, and misinformation. Dr. Coon is also interested in the role of the pharmacist in the opioid epidemic and the spread of evidence-based harm reduction strategies. Dr. Coon's current research interests: Substance Use Disorders / Opioid Use Disorder, primary prevention of cardiovascular disease, healthcare disparities.

Recent Publications

• Durell N Franks R Coon S Cowart K Carris N. Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss Journal of Pharmacy Technology. , 2022.
• Clements JN Emmons RP Anderson SL Chow M Coon S Irwin AN Murkherjee SM Sease JM Thrasher K Witek S. Current and future state of quality metrics and performance indicators in comprehensive medication management for ambulatory care pharmacy practice Journal of the American College of Clinical Pharmacy. , 2021.
• Coon SA Hill LG Hutchison RW et a. Mobilizing pharmacists to address the opioid crisis: A joint opinion of the ambulatory care and adult medicine practice and research networks of the American College of Clinical Pharmacy Journal of the American College of Clinical Pharmacy. , 2020.
• Badowski ME, Walker S, Bacchus S, Bartlett S, Chan J, Cochran KA, Coon S, Liedtke M, Phillips BG, White T. Providing Comprehensive Medication Management in Telehealth. Pharmacotherapy. 38(2) : e7-e16, 2018.
• Coon SA, Crannage EF, Kerwin LC, Guyton JE. Semaglutide once-weekly: improved efficacy with a new safety warning. Expert review of clinical pharmacology. 11(11) : 1061-1072, 2018.
• Coon SA, Brooks AD, Wolff SE. Primary prevention aspirin use in high-risk patients: A pharmacist intervention and comparison of risk stratification tools. Journal of the American Pharmacists Association : JAPhA. 57(5) : 585-590, 2017.
• Gabay M, Smith JA, Chavez ML, Goldwire M, Walker S, Coon SA, Gosser R, Hume AL, Musselman M, Phillips J, Abe AM. White Paper on Natural Products. Pharmacotherapy. 37(1) : e1-e15, 2017.
• Coon SA, Stevens VW, Brown JE, Wolff SE, Wrobel MJ. Comparison of dietary supplement product knowledge and confidence between pharmacists and health food store employees. Journal of the American Pharmacists Association : JAPhA. 55(2) : 161-8, 2015.

Positions Held

• Assistant Professor (Department of Pharmacy Practice., College of Pharmacy, St. Louis College of Pharmacy 2017 - 2019)
• Assistant Professor (College of Pharmacy, Oregon State University/Oregon Health & Science University 2015 - 2017)